Key facts
- It has raised $7.1M; the latest was Later Stage VC ($7.1M) in Jan 2025.
- Notable investors include University of Minnesota Office for Technology Commercialization, Minnesota Department of Employment and Economic Development, Silver Blue, Silver Blue., University of Minnesota.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Jord BioScience
- ·The full record, as it builds
Funding rounds
No funding rounds for Jord BioScience are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jord BioScience
Operator of a bioscience technology company intended to enhance regenerative agriculture through advanced microbial systems. The company offers microbial inoculants designed to work synergistically with existing commercial products, enabling agricultural manufacturers to enhance the performance of their product offerings.
- Sector
- Materials and Resources
- HQ
- Saint Paul, MN, United States
- Founded
- 2019
- Employees
- 13
- Website
- jordbioscience.com/
- Ownership
- Privately Held (backing)
Jord BioScience doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jord BioScience shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jord BioScience in its N-PORT filings yet. We sweep new filings monthly.